Press release
Gastric Cancer Drugs Market with Result, Challenges, Research, Froecast Growth 2019, Global Demand
Gastric cancer refers to the cancer arising from lining of stomach. It may lead to uncontrolled growth of malignant cells that originate in stomach tissue and forms a tumor in any part of the stomach. Mainly there are five types of gastric cancer namely adenocarcinoma, squamous cell cancer, lymphoma, gastrointestinal stromal tumors, neuroendocrine tumors. From all these types, adenocarcinoma types of cancer originates from the innermost lining of stomach and accounts for more than 90% of all gastric tumors. Dysphagia, frequent burping, heartburn, stomachache are some of the early stomach cancer symptoms. The drugs of gastric cancers works on extracellular and intracellular domain of HER2 receptor of stomach and continuously suppress the tumor proliferation that lead to cell stasis and death.Get Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1853
According to World Health Organization, approximately 800,000 cancer related deaths are caused by gastric cancer every year and American Cancer Society estimated that in 2013 approximately 21,600 cases of gastric cancer will be diagnosed. This increasing incidences of gastric cancer drives the market of gastric cancer drugs. In addition, introduction of new therapies like Taxotere, Xeloda and Herceptin are also expected to propel the demand for gastric cancer drugs. However, less number of commercially available drugs for the treatment of gastric cancer may hinder the market growth.
The global Gastric Cancer Drugmarket is categorized based on the following:
By Class of Drugs
Doxorubicin Hydrochloride
Fluorouracil
Trastuzumab
Mitomycin C
Docetaxel
Imatinib
Sunitinib
Geographically, China and Japan dominate the global gastric cancer drug market due to large patient base and rise in treatment seeking population in these regions.Also, with the rise in geriatric population the number of people diagnosed with gastric cancer also increases which ultimately impacts the growth of gastric cancer drugs in these markets. The market of gastric cancer drug in North America and Europeholds a strong growth as the key players are domiciled in these regions. With the rise in uptake of gastric cancer drugs namely is Herceptin, Erbitux and Afitnitor also accentuates the growth of these drugs in the North American and European market.However, the total number of newly diagnosed patients are five times greater in China and Japan than the United States, making Japanese and Chinese market commercially attractive for developers.
View TOC for this Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1853
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Drugs Market with Result, Challenges, Research, Froecast Growth 2019, Global Demand here
News-ID: 757690 • Views: …
More Releases from Transparency Market Research
Global Transfection Reagents and Equipment Market to Reach USD 2.4 Bn by 2035, D …
The global Transfection Reagents and Equipment Market is on a steady growth trajectory, supported by accelerating advancements in genetic research, increasing investments in cell and gene therapy, and the widespread adoption of cutting-edge gene-editing technologies such as CRISPR. Valued at US$ 1.2 Bn in 2024, the market is projected to reach US$ 2.4 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2035.
Access…
SNP Genotyping and Analysis Market Expanding at 19.8% CAGR Through 2035 - By Sam …
The global SNP genotyping and analysis market was valued at US$ 27.4 billion in 2024 and is projected to reach US$ 199.2 billion by 2035, expanding at a robust compound annual growth rate (CAGR) of 19.8% during the forecast period from 2025 to 2035.
Explore pivotal insights and conclusions from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=432
This exponential growth trajectory reflects the rising adoption of genomic technologies, increasing emphasis on personalized and…
3D Printing Materials Market Outlook 2035: Global Market to Surge from US 3.6 Bi …
The global 3D printing materials market is undergoing a transformative expansion, supported by rapid advancements in additive manufacturing technologies and accelerating adoption across industrial and commercial sectors. In 2024, the market was valued at US$ 3.6 Bn. Driven by strong demand from automotive, aerospace, healthcare, and consumer goods industries, the market is projected to reach an impressive US$ 41.1 Bn by 2035, registering a robust compound annual growth rate (CAGR)…
Small Modular Nuclear Reactors Market Outlook 2035: Advancing from US$ 5.9 Billi …
The global small modular nuclear reactors (SMRs) market is gaining strategic momentum as countries seek reliable, low-carbon, and scalable energy solutions to support decarbonization goals and long-term energy security. Valued at US$ 5.9 billion in 2024, the SMR market is projected to reach US$ 10.5 billion by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Unlike conventional large nuclear plants, SMRs offer flexible deployment, reduced capital risk,…
More Releases for Gastric
Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Cancer Drugs Market Size By 2025?
In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market?
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,…
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market?
The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that…
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gastric Cancer…
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market.
Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126
The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
